PRESCRIPTION DRUGS: Your Patients Need Better Access To Drugs Under Part D, Groups Say

Article Overview

This article reports on patient advocacy groups’ federal policy priorities related to prescription drug access and safety. It discusses requests for increased NIH funding, concerns about Medicare Part D implementation from the patient perspective, and calls for FDA-related actions tied to drug safety, approval resources, and patient access. The piece is useful for readers tracking health policy, patient advocacy, and broad federal programs affecting prescription drug coverage and regulation.